
Keywords: گنوزین سیکل 3 '، 5'-مونوفسفره; basal cell carcinoma; melanoma; meta-analysis; PDE5 inhibitor; squamous cell carcinoma; BCC; basal cell carcinoma; cGMP; cyclic guanosine-3â²,5â²-monophosphate; CI; confidence interval; NOS; Newcastle-Ottawa quality-assessment scale; OR; odds ratio; PDE